JP2011511090A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011511090A5 JP2011511090A5 JP2010546007A JP2010546007A JP2011511090A5 JP 2011511090 A5 JP2011511090 A5 JP 2011511090A5 JP 2010546007 A JP2010546007 A JP 2010546007A JP 2010546007 A JP2010546007 A JP 2010546007A JP 2011511090 A5 JP2011511090 A5 JP 2011511090A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- cells
- growth factor
- layer
- eye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2699008P | 2008-02-07 | 2008-02-07 | |
| US9322808P | 2008-08-29 | 2008-08-29 | |
| PCT/US2009/033275 WO2009100253A1 (en) | 2008-02-07 | 2009-02-05 | Rescue of photoreceptors by intravitreal administation of an expression vector encoding a therapeutic protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011511090A JP2011511090A (ja) | 2011-04-07 |
| JP2011511090A5 true JP2011511090A5 (enExample) | 2013-03-28 |
Family
ID=40939054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010546007A Ceased JP2011511090A (ja) | 2008-02-07 | 2009-02-05 | 治療用タンパク質をコードする発現ベクターの硝子体内投与による光受容体のレスキュー方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8242093B2 (enExample) |
| EP (1) | EP2247258A4 (enExample) |
| JP (1) | JP2011511090A (enExample) |
| CN (1) | CN101980668A (enExample) |
| AU (1) | AU2009212309B2 (enExample) |
| CA (1) | CA2713755A1 (enExample) |
| WO (1) | WO2009100253A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009100253A1 (en) * | 2008-02-07 | 2009-08-13 | Ceregene, Inc. | Rescue of photoreceptors by intravitreal administation of an expression vector encoding a therapeutic protein |
| GB201103062D0 (en) * | 2011-02-22 | 2011-04-06 | Isis Innovation | Method |
| CN103459593A (zh) * | 2011-02-25 | 2013-12-18 | 独立行政法人理化学研究所 | 视网膜色素上皮细胞片层的生产方法 |
| EP2872183B1 (en) * | 2012-07-11 | 2018-09-26 | The Trustees Of The University Of Pennsylvania | Aav-mediated gene therapy for rpgr x-linked retinal degeneration |
| WO2015044704A1 (en) * | 2013-09-30 | 2015-04-02 | Sanofi | Use of neuroglobin agonist for preventing or treating mitochondrial rcci and/or rcciii deficiency disease |
| RU2723101C2 (ru) * | 2013-12-06 | 2020-06-08 | Инсерм (Инститьют Насьонал Де Ла Санте Ет Де Ла Решерш Медикаль) | Вектор, способ лечения хороидермии, способ селективной экспрессии полинуклеотида |
| US10293059B2 (en) * | 2015-04-09 | 2019-05-21 | Cornell University | Gene therapy to prevent reactions to allergens |
| EP3384036B1 (en) * | 2015-12-04 | 2021-02-24 | Sorbonne Université | Promoters and uses thereof |
| CA3025975A1 (en) * | 2016-04-29 | 2017-11-02 | Gensight Biologics Sa | Optogenetic visual restoration using chrimson |
| PL239642B1 (pl) * | 2018-08-16 | 2021-12-20 | Pomorski Univ Medyczny W Szczecinie | Kompozycja do doszklistkowego podawania białka leczniczego |
| WO2022086990A1 (en) * | 2020-10-22 | 2022-04-28 | Visgenx, Inc. | Elovl2 constructs for human gene therapy |
| AU2023390868A1 (en) * | 2022-12-05 | 2025-06-19 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Pigment epithelium-derived factor peptides and use for treating retinal degeneration |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5932479A (en) | 1988-09-26 | 1999-08-03 | Auburn University | Genetic engineering of plant chloroplasts |
| CA2293492A1 (en) * | 1997-06-11 | 1998-12-17 | Martin Berry | Cns neuroregenerative compositions and methods of use |
| EP1154691A4 (en) * | 1999-01-05 | 2004-07-07 | Massachusetts Eye & Ear Infirm | TARGETED ADMINISTRATION OF REGULATED RELEASE MEDICINE TO RETINA AND CHOROID THROUGH SCLEROTIC |
| WO2000054813A2 (en) * | 1999-03-15 | 2000-09-21 | Chiron Corporation | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| US6943153B1 (en) * | 1999-03-15 | 2005-09-13 | The Regents Of The University Of California | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| AU2001241809A1 (en) | 2000-02-29 | 2001-09-12 | Auburn University | Genetic engineering of drought tolerance via a plastid genome |
| EP2080803B1 (en) | 2000-03-01 | 2011-05-25 | Auburn University | Plastid transformation vectors for expressing proinsulin fused to the cholera toxin B-subunit in plants |
| US7354760B2 (en) | 2001-12-26 | 2008-04-08 | University Of Central Florida Research Foundation, Inc. | Expression of protective antigens in transgenic chloroplasts |
| AU2003253781A1 (en) | 2002-07-03 | 2004-01-23 | University Of Central Florida | Expression of human interferon in transgenic chloroplasts |
| WO2006101634A1 (en) | 2005-02-17 | 2006-09-28 | The Regents Of The University Of California | Müller cell specific gene therapy |
| US20060188481A1 (en) * | 2005-02-22 | 2006-08-24 | Saitama Medical School | Methods for prophylactically or therapeutically treating an animal for an ocular-related disorder |
| JP2008537478A (ja) | 2005-02-24 | 2008-09-18 | ザ・スクリプス・リサーチ・インステイチユート | 単離骨髄球様骨髄細胞集団及びそれを用いた治療方法 |
| AU2006309281B2 (en) | 2005-05-27 | 2011-11-03 | University Of Central Florida | Chloroplasts engineered to express pharmaceutical proteins |
| WO2009100253A1 (en) * | 2008-02-07 | 2009-08-13 | Ceregene, Inc. | Rescue of photoreceptors by intravitreal administation of an expression vector encoding a therapeutic protein |
-
2009
- 2009-02-05 WO PCT/US2009/033275 patent/WO2009100253A1/en not_active Ceased
- 2009-02-05 CA CA2713755A patent/CA2713755A1/en not_active Abandoned
- 2009-02-05 AU AU2009212309A patent/AU2009212309B2/en not_active Ceased
- 2009-02-05 JP JP2010546007A patent/JP2011511090A/ja not_active Ceased
- 2009-02-05 US US12/366,596 patent/US8242093B2/en not_active Expired - Fee Related
- 2009-02-05 EP EP09707354A patent/EP2247258A4/en not_active Withdrawn
- 2009-02-05 CN CN2009801043603A patent/CN101980668A/zh active Pending
-
2011
- 2011-08-17 US US13/212,078 patent/US8420619B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7182873B2 (ja) | 多重ベクターシステム及びその使用 | |
| RU2018142768A (ru) | Варианты капсидов аденоассоциированного вируса и способы их применения | |
| HRP20211024T1 (hr) | Aav vektori za gensku terapiju mrežnice i cns-a | |
| UA130154C2 (uk) | Спосіб безклітинного одержання днк-вектора з замкненими кінцями | |
| JP2020532981A (ja) | 修飾型閉端ｄｎａ（ｃｅｄｎａ） | |
| EP3387137A1 (en) | TARGETING PEPTIDES FOR DIRECTING ADENO-ASSOCIATED VIRUSES (AAVs) | |
| JP2015523379A5 (enExample) | ||
| HRP20171334T1 (hr) | Virioni adeno-povezanog virusa s kapsid varijantom i postupci njihove upotrebe | |
| RU2017121593A (ru) | Векторы aav, нацеленные на центральную нервную систему | |
| CN113301956B (zh) | 控制器官功能的基因治疗方法 | |
| JP2017506521A5 (enExample) | ||
| JP2015501156A5 (enExample) | ||
| JP2023528801A5 (enExample) | ||
| Hellstrom et al. | Retinal ganglion cell gene therapy and visual system repair | |
| JP7289306B2 (ja) | 網膜障害を治療するための組成物及び方法 | |
| ES2199932T3 (es) | Poxvirus recombinante y vacuna estreptococica que contiene proteina m. | |
| JP2021511030A5 (enExample) | ||
| IL308645A (en) | Viral vectors comprising rdh12 coding regions and methods of treating retinal dystrophies | |
| CN112029773B (zh) | 编码bdnf的核酸及其应用 | |
| US12472270B2 (en) | Methods and compositions for reprogramming Müller Glia | |
| CN115927472A (zh) | 一种抗vegf抗体体内表达系统的构建和应用 | |
| JP2022523050A5 (enExample) | ||
| CA3228666A1 (en) | Compositions and methods for transgene expression | |
| KR20210130578A (ko) | 폐섬유증 치료 또는 예방을 위한 세포 치료제 조성물 | |
| JP2022512667A5 (enExample) |